FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Commissioners Suggestions for Martin Makary

FDA commissioner Robert Califf and three former commissioners offer their perspectives on the ways the incoming administration can succeed at FDA.

latest-news-card-1
Human Drugs

Boehringer Schizophrenia Cognition Trial Misses Endpoints

Boehringer Ingelheim reports disappointing data from its CONNEX clinical trial program evaluating iclepertin in cognitive impairment in adults with sc...

latest-news-card-1
Medical Devices

Medline Fluid Delivery Sets Recalled

Medline Industries recalls its Medline Fluid Delivery Set with Drip Chamber because the devices were incorrectly assembled.

latest-news-card-1
Medical Devices

FDA Early Alert on Fresenius Pump Software Updates

Citing potentially lethal risk, an FDA Early Alert says Fresenius Kabi is recommending updates to some software for its Ivenix Infusion System.

latest-news-card-1
Human Drugs

FDA Warns Against Using Epinephrine Nasal Solution

An FDA alert warns healthcare professionals not to use unapproved epinephrine nasal solutions manufactured by BPI Labs and Endo USA.

latest-news-card-1
Federal Register

Guide on Reducing Malaria Transmission

Federal Register notice: FDA makes available a draft guidance entitled Recommendations To Reduce the Risk of Transfusion Transmitted Malaria.

latest-news-card-1
Human Drugs

FDA Complete Response on Ataras Ebvallo

FDA sends Atara Biotherapeutics a complete response letter on its BLA for Ebvallo (tabelecleucel), a monotherapy treatment for adult and pediatric pat...

latest-news-card-1
Human Drugs

Anti-Neuropathy Guidance for Cancer Drugs

FDA publishes a draft guidance on developing drugs to prevent and treat cancer-related chemotherapy-induced peripheral neuropathy.

latest-news-card-1
FDA General

FDA Policy Head Lands at King & Spalding

King & Spalding hires former FDA associate commissioner for policy Lauren Roth as a partner on the FDA and Life Sciences team.

latest-news-card-1
Human Drugs

Lillys Omvoh Wins Expanded Approval

FDA approves Eli Lillys Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohns disease in adults.